Ticker Scorecard - ABOS Basics Company: Acumen Pharmaceuticals, Inc. IPO Date: July 1, 2021 Sector: Healthcare Industry: Biotech Market Cap: $83.51M Activated in VL: True Average Daily Range Avg Daily Range: $0.21 | 3.67% Avg Daily Range (30 D): $0.05 | 2.99% Avg Daily Range (90 D): $0.08 | 3.43% Institutional Daily Volume Avg Daily Volume: .34M Avg Daily Volume (30 D): .26M Avg Daily Volume (90 D): .25M Trade Size Avg Trade Size (Sh.): 113 Avg Trade Size (Sh.) (30 D): 165 Avg Trade Size (Sh.) (90 D): 148 Institutional Trades Total Inst.Trades: 56 Avg Inst. Trade: $2.16M Avg Inst. Trade (30 D): $.68M Avg Inst. Trade (90 D): $.79M Avg Inst. Trade Volume: .33M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.29M Avg Closing Trade (30 D): $8.78M Avg Closing Trade (90 D): $8.78M Avg Closing Volume: 525.35K     News Nov 26, 2024 @ 9:00 PM Acumen Pharmaceuticals to Participate in the 7th A... Source: N/A Nov 6, 2024 @ 9:00 PM Acumen Pharmaceuticals to Participate in the UBS G... Source: N/A Oct 23, 2024 @ 12:00 PM Acumen Pharmaceuticals to Deliver Late-Breaking Pr... Source: N/A Jul 28, 2024 @ 11:30 AM Acumen Pharmaceuticals Presents Patient Experience... Source: N/A Jul 24, 2024 @ 12:36 PM 4 High-Risk, High-Reward Small-Cap Stocks to Play ... Source: Ismael De La Cruz Financials   TTM Q2 2024 Q1 2024 Basic EPS $-.5 $-.34 $-.25 Diluted EPS $-.5 $-.34 $-.25 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -29.77M $ -20.54M $ -14.87M Operating Income / Loss $ -32.27M $ -24.38M $ -17.77M Cost of Revenue $ $ $ Net Cash Flow $ -34.77M $ 21.03M $ -19.96M PE Ratio